Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV000770541 | SCV000901988 | uncertain significance | Cardiomyopathy | 2015-12-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002370031 | SCV002686965 | uncertain significance | Cardiovascular phenotype | 2023-01-23 | criteria provided, single submitter | clinical testing | The p.D317N variant (also known as c.949G>A), located in coding exon 8 of the DSC2 gene, results from a G to A substitution at nucleotide position 949. The aspartic acid at codon 317 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV002533966 | SCV003302612 | uncertain significance | Arrhythmogenic right ventricular dysplasia 11 | 2023-12-21 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 317 of the DSC2 protein (p.Asp317Asn). This variant is present in population databases (rs769219956, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with DSC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 626837). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on DSC2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
All of Us Research Program, |
RCV003999948 | SCV004822555 | uncertain significance | Familial isolated arrhythmogenic right ventricular dysplasia | 2023-12-01 | criteria provided, single submitter | clinical testing |